安赫多尼亚:当前和未来的治疗方法
1Department of Medicine and Surgery Kore University of Enna Enna Italy.
PCN reports : psychiatry and clinical neurosciences
|March 25, 2025
概括
包括药物,神经调节和行为疗法在内的安赫多尼亚干预措施,有望改善患者的治疗结果和缓解率. 根据个人奖励干扰量身定制治疗是获得最佳结果的关键.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 无情是各种精神疾病的核心症状,严重损害功能和阻碍恢复.
- 目前的治疗方法对安赫多尼亚的疗效通常有限,因此需要探索各种治疗途径.
研究的目的:
- 提供对目前和新兴的干预措施的全面概述.
- 综合关于药理学,神经调节,行为和基于生活方式的方法有效性的证据.
主要方法:
- 叙述对现有关于无虫治疗的文献的综述.
- 对调查各种治疗方式的研究进行分析,包括药物,神经调节,心理治疗和新型药物.
主要成果:
- 药理学药物,如西,阿戈梅拉丁,布普罗,胺和布雷克斯皮普拉,表现出抗安赫多尼效应,优于传统的SSRI和SNRIs.
- 神经调节技术 (rTMS,tDCS,tVNS) 和心理治疗 (行为激活,正念,品尝) 在改善无情感方面表现出有效性.
- 新兴的治疗方法,如aticaprant和psilocybin表现出对anhedonia有希望的结果.
结论:
- 改善无症与增强的心理社会功能,生活质量和持续缓解有关.
- 常规评估和针对特定奖励通路干扰的量身定制干预措施对于优化患者结果至关重要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
173
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
173
01:28Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
01:22Alzheimer's Disease: Treatment
137
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
137
01:25Antidepressant Drugs: Overview
341
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
341
01:30Electroconvulsive Therapy
20
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
20
01:03Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K